CAPELLO, Michela
 Distribuzione geografica
Continente #
NA - Nord America 2.600
EU - Europa 1.495
AS - Asia 668
AF - Africa 37
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 2
Totale 4.842
Nazione #
US - Stati Uniti d'America 2.588
CN - Cina 432
IT - Italia 240
DK - Danimarca 237
SE - Svezia 221
IE - Irlanda 143
AT - Austria 118
UA - Ucraina 109
DE - Germania 90
FR - Francia 76
FI - Finlandia 75
KR - Corea 54
PL - Polonia 49
TW - Taiwan 49
GB - Regno Unito 45
SN - Senegal 36
BE - Belgio 34
AU - Australia 32
SG - Singapore 29
VN - Vietnam 29
IN - India 20
JP - Giappone 20
NL - Olanda 13
BY - Bielorussia 11
CA - Canada 9
RU - Federazione Russa 9
UZ - Uzbekistan 8
EU - Europa 7
HK - Hong Kong 6
RO - Romania 6
TR - Turchia 5
CH - Svizzera 3
ES - Italia 3
ID - Indonesia 3
MX - Messico 3
BN - Brunei Darussalam 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
PH - Filippine 2
PK - Pakistan 2
AL - Albania 1
BR - Brasile 1
BT - Bhutan 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.842
Città #
Chandler 400
Ann Arbor 322
Beijing 231
Wilmington 147
Dublin 142
Houston 137
Dearborn 135
Vienna 118
Fairfield 114
Ashburn 111
Nyköping 83
Jacksonville 80
Woodbridge 70
Guangzhou 61
Seattle 52
Cambridge 50
Medford 48
Villeurbanne 45
Princeton 44
Torino 44
Warsaw 44
Fremont 40
Taipei 35
Brussels 33
Pisa 32
Redwood City 27
Dong Ket 24
Shanghai 20
Turin 20
Boardman 19
Norwalk 17
San Mateo 16
Washington 16
Boston 13
Chengdu 11
Nanjing 11
Milan 10
Wayne 10
Wuhan 10
Melbourne 9
Phoenix 9
Shenyang 9
Falls Church 8
San Diego 8
Seoul 8
Zhengzhou 8
Halmstad 7
Lincoln 7
Provo 7
Heidelberg 6
Paris 6
Changchun 5
Hefei 5
Ichikawa 5
Kunming 5
Los Angeles 5
Monash 5
New Taipei 5
New York 5
Piemonte 5
Polska 5
Volpago Del Montello 5
Xian 5
Clayton 4
Dallas 4
Düsseldorf 4
Jinan 4
Naples 4
Tappahannock 4
Tokyo 4
Toronto 4
Coimbatore 3
Delhi 3
Des Moines 3
Farmington 3
Fuzhou 3
Galati 3
Hangzhou 3
Jakarta 3
Lexington 3
London 3
Munich 3
Nanchang 3
Nanning 3
San Vito Chietino 3
Silver Spring 3
Villadose 3
Bandar Seri Begawan 2
Beltsville 2
Buffalo 2
Canberra 2
Central District 2
Cerveteri 2
Chapel Hill 2
Copenhagen 2
Edinburgh 2
El Paso 2
Erlangen 2
Genoa 2
Genova 2
Totale 3.100
Nome #
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 407
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers 321
Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation. 270
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 264
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 220
Chemotherapy effects on immune-complexes in pancreatic ductal adenocarcinoma patients serum 218
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 213
Proteomic data analysis of pancreatic cancer patient sera revealed how chemotherapy shapes the immunogenicity of developing tumors 196
α-enolase: a promising therapeutic and diagnostic tumor target 184
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 170
An integrative transcriptomic analysis of glycolytic genes reveals distinct metabolic subtypes in pancreatic cancer 169
Three are better than one: plasminogen receptors as cancer theranostic targets. 137
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 119
Autoantibody signature in human ductal pancreatic adenocarcinoma 108
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 104
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 103
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 100
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 100
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 99
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 97
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 90
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 85
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 84
Serological proteome analysis (SERPA) as a tool for the identification of tumor antigens capable of eliciting immune responses in chronic lymphocytic leukemia (CLL) 84
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 82
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 80
Towards pancreatic cancer diagnosis using EIS biochips. 79
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 79
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 78
PHOSPHOPROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS DIFFERENTIAL PHOSPHORYLATION OF CELL ADHESION, CELL JUNCTION AND STRUCTURAL PROTEINS 76
Mass spectrometry analysis reveals novel O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells 73
QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION (QCM-D) AS TOOL TO EXPLOIT ANTIGEN-ANTIBODY INTERACTIONS IN PANCREATIC DUCTAL ADENOCARCINOMA DETECTION 71
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 68
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma 66
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells. 62
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 61
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells 58
Procedimento e kit per la diagnosi in vitro dell’adenocarcinoma duttale pancreatico o per determinare la predisposizione all’adenocarcinoma duttale pancreatico 53
Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations. 50
Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells 49
Totale 5.027
Categoria #
all - tutte 10.783
article - articoli 0
book - libri 0
conference - conferenze 4.424
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019262 0 0 0 0 0 0 0 0 33 53 103 73
2019/20201.196 49 56 81 151 81 184 112 57 124 97 105 99
2020/2021785 99 77 52 62 77 67 55 49 64 49 61 73
2021/2022608 20 17 18 35 22 35 57 32 23 58 168 123
2022/2023967 80 98 17 131 92 216 64 73 111 23 40 22
2023/2024274 66 51 33 22 11 57 4 29 1 0 0 0
Totale 5.027